March 19, 2025 Non Regulatory AcuCort receives renewed marketing authorisation for Zeqmelit® in Norway
March 17, 2025 Non Regulatory AcuCort receives renewed marketing authorisation for Zeqmelit® in Denmark
March 4, 2025 Non Regulatory AcuCort’s medicinal product receives renewed marketing authorisation from the Swedish Medical Products Agency
January 27, 2025 Non Regulatory Promising results from AcuCort’s Phase IV study – scientific articles under preparation for international publication
October 2, 2024 Non Regulatory AcuCort granted extended SME status by the European Medicines Agency (EMA)
September 9, 2024 Non Regulatory AcuCort Presents Study Results at the ISPOR Scientific Conference in Barcelona
June 11, 2024 Non Regulatory Very High Willingness to Pay for Zeqmelit® According to Publication in International Scientific Journal
May 21, 2024 Non Regulatory Study on Patients’ Willingness to Pay Published in an International Scientific Journal
February 1, 2024 Non Regulatory AcuCort presents at Invest Live: Update on the process leading up to the launch of Zeqmelit®
November 30, 2023 Non Regulatory CORRECTION: AcuCort publishes the Interim Report for the first quarter 2023 (in Swedish)
September 1, 2023 Non Regulatory (Retransmission) AcuCort signs partnership agreement for the four major Nordic countries with Unimedic Pharma
May 15, 2023 Non Regulatory AcuCort is granted trademark protection for Zeqmelit® in the United Kingdom
January 24, 2023 Non Regulatory AcuCort has submitted the price and subsidy application to TLV regarding Zeqmelit®
September 28, 2022 Non Regulatory AcuCort reports positive results from the company’s questionnaire study about allergy treatments
September 22, 2022 Non Regulatory AcuCort presents at Nordic Life Science Days in Malmö on September 29, 2022
February 5, 2020 Non Regulatory AcuCort CEO to present at BIO Europe Spring in Paris and BioStock Live in Stockholm